Table 1.
Patient characteristics and disease outcome.
| Gender, n (%) | Male – 15 (65) Female – 8 (35) |
| Age at diagnosis (yr) | Median 43 (19–78) |
| Tumor volume at presentation, cc (%) | Mean 810 (55–4000) cc |
| Pathology subtype, n (%)a | MLS – 6 (26) Dedifferentiated liposarcoma – 6 (26) MPNST – 4 (17) UPS – 2 (9) Others – 5 (22) |
| Tumor location, n (%) | Lower extremity – 11 (48) Retroperitoneal – 7 (30) Chest wall – 5 (22) |
| Depth, n (%) | Deep – 22 (96) Superficial – 1 (4) |
| Staging at presentation, n (%) | Non-metastatic – 22 (96) Metastatic – 1 (4) |
| Type of surgery, n (%) | Wide local excision – 15 (66) Amputation – 1 (4) Laparotomy – 7 (30) |
| Extent of resection, n (%) | R0 – 18 (79) R1 – 4 (17) R2 – 1 (4) |
| Status at last follow-up, n (%) | No evidence of disease – 18 (79) Alive with disease – 3 (13) Dead of other causes – 0 Dead of disease – 2 (8) |
a
Abbreviations: MLS, myxoid liposarcoma; MPNST, malignant peripheral nerve sheath tumor; UPS, undifferentiated pleomorphic sarcoma.